Revolutionizing Skin Cancer and Neurological Disorder Diagnostics through Innovative Immunotherapy Targets and Skin Biopsy Tests

Published: Jan 2024

The global skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030). The rising demand of skin biopsy in skin cancer treatment is a key factor driving the growth of the global market. Skin biopsy help in differentiate between benign and malignant lesions, differentiate between cancer and non-melanoma cancers, and aid in immunohistochemistry (IHC) biomarker analysis. They also aid in research and clinical trials, providing tissue samples for molecular and genetic studies, assessing the efficacy of new treatments, and identifying infectious diseases.  

Browse the full report description of “Skin Biopsy Market Size, Share &Trends Analysis Report by Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), by Indication (Skin Cancer Diagnosis and Staging, Actinic keratosis, Dermatitis, and Others) and by End-User (Hospitals, Diagnostic Laboratories, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/skin-biopsy-market

Syn-One Test, a pioneering advancement in neurological disorder diagnostics, uses skin biopsies to differentiate between dementia with Lewy bodies and Alzheimer's disease.in May 2022, CND Life Sciences, has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH). The company's second NIH SBIR Phase II award to study and advance the application of the Syn-One Test, the only commercially available test that uses skin biopsies to help clinicians differentiate between serious neurologic disorders such as dementia with Lewy bodies (DLB) and Alzheimer's disease.

Market Coverage

The market number available for – 2022-2030

Base year- 2022

Forecast period- 2023-2030

Segment Covered- 

o By Type

o By Indication

o By End-User

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- includes Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

Who is the leader in the market?

How are players addressing challenges to sustain growth?

Where is the investment opportunity?

Global Skin Biopsy Market Report Segment

By Type

  • Shave Biopsy
  • Punch Biopsy
  • Excisional Biopsy

By Indication

  • Skin Cancer Diagnosis and Staging
  • Actinic keratosis
  • Dermatitis
  • Others (Hair and Nail Disorders, and Autoimmune Skin Disorders)

By End-User

  • Hospitals 
  • Diagnostic Laboratories
  • Others (Research Institutions and Academic Centres, Dermatologists and Pathologists)

Global Skin Biopsy Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/skin-biopsy-market